|
Volumn 17, Issue 1, 2006, Pages 5-
|
Intermittent dosing of biologics for psoriasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEFACEPT;
ANTIPSORIASIS AGENT;
ETANERCEPT;
METHOTREXATE;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG INTERMITTENT THERAPY;
DRUG RESPONSE;
DRUG USE;
DRUG WITHDRAWAL;
EDITORIAL;
HUMAN;
LONG TERM CARE;
PHOTOTHERAPY;
PRIORITY JOURNAL;
PSORIASIS;
PUBLICATION;
BIOLOGICAL RESPONSE MODIFIERS;
HUMANS;
IMMUNOGLOBULIN G;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
EID: 32644462555
PISSN: 09546634
EISSN: 14711753
Source Type: Journal
DOI: 10.1080/09546630600549261 Document Type: Editorial |
Times cited : (1)
|
References (0)
|